Rising healthcare costs and AI transformation: Beyond the Tipping Point
- Family healthcare costs are climbing past $35,000 annually, driven largely by outpatient facility charges, pharmacy spend, and new-to-market therapies. Employers have more tools to manage this than most realize.
- The traditional fully insured model is designed to benefit carriers. Self-insured and captive solutions are increasingly accessible to mid-sized life science companies, and CLS members now have a purpose-built option through CLS Insured.
- Know your network before a disruption forces you to. Understanding provider contract timelines and having a contingency plan in place is a basic fiduciary responsibility, not a nice-to-have.
- 68% of jobs in life sciences and pharma may require fundamental reimagination by 2030. AI adoption without organizational alignment across people, technology, and finance is a recipe for disruption rather than a path through it.
- The human skills that will matter most are continuous learning, adaptability, problem solving, and communication. Soft skills are now strategic assets.
Rising healthcare costs and AI-driven workforce transformation are two of the most pressing issues facing employers today. On April 8 in South San Francisco and April 9 in San Diego, California Life Sciences and HUB International brought together HR leaders, finance executives, and operations professionals from across the life sciences community for Beyond the Tipping Point, an event designed to cut through the noise.
Here’s what we took away from the half-day events.
The healthcare cost crisis is structural, not cyclical
Experts from Milliman opened both events with a clear-eyed assessment of where healthcare costs are headed and why. Outpatient facility charges and pharmacy spend are among the fastest-growing drivers of cost increases, and the arrival of new-to-market drugs, including GLP-1 medications, is reshaping employer plan obligations in real time. As life-changing therapies for conditions like cancer and rare disease become more prevalent, claims are not only growing in size but also in duration.
The message from Milliman was direct: family healthcare costs are now climbing past $35,000 annually, and Employee Retirement Income Security Act (ERISA) fiduciary responsibilities mean employers can no longer afford to be passive about plan design. The goal of any insurance strategy, they emphasized, should be to deliver the best possible clinical outcomes for employees while also remaining competitive enough to attract top talent.
Self-funding is no longer just for the Fortune 50
ParetoHealth and HUB International made the case that the traditional fully insured model is structurally designed to benefit carriers, not employers. Broadening the time horizon on insurance planning, from the standard annual renewal cycle to a three-to-five year strategic view, opens the door to more meaningful cost management decisions.
The session also introduced the CLS Insured captive solution, a partnership between CLS and HUB International that gives life science companies with 100 to 1,500 eligible U.S. employees access to the risk-sharing and transparency benefits of self-insurance, with the protective structure of a fully insured plan. For employers who have traditionally felt locked out of these models, this represents a real shift in what’s available.
AI is reshaping life sciences work faster than most organizations are moving
Diego Castresana of the McKinsey Global Institute, who presented at the South San Francisco event, and Maria Jesus Ramirez, who joined in San Diego, brought McKinsey’s latest research on AI and workforce transformation to the room. Their findings were striking: 68% of jobs in the life sciences and pharma sector may require fundamental reimagination by 2030 as work shifts across people, AI agents, and automation.
For leaders, the imperative isn’t just technology adoption. It’s organizational alignment. Getting heads of people, technology, and finance in the same room to define what responsible AI implementation looks like in your specific workflows is no longer optional. The human skills that will matter most in this transition are continuous learning, adaptability, problem solving, and communication.
Know your plan, know your network
Rick Neale, EVP and Chief Growth Officer at Scripps Health, delivered the keynote at the San Diego event, drawing on his direct experience in the Scripps/Anthem contract negotiations to offer an unfiltered perspective on the structural pressures bearing down on health systems today.
His advice for employers was clear: understand how long the providers in your network will be under contract with your insurer, and have a contingency plan before you ever need to invoke it. He also emphasized the importance of having visibility into where healthcare dollars are actually going, and the long-term cost benefits of investing in employee health promotion and preventive care.
On AI in healthcare specifically, Neale urged caution alongside enthusiasm. Ensuring consistency of care as AI tools are introduced is essential. AI-generated answers are helpful but can’t exist in a vacuum; patients need continuous engagement and human touchpoints.
The cost of waiting
The throughline across both events was urgency: the employers who will navigate the next five years most effectively are those who start making strategic decisions now, on healthcare financing, on AI governance, and on workforce development rather than waiting for a crisis to force their hand.
We’re grateful to everyone who joined us in South San Francisco and San Diego, and to our partners at HUB International, Milliman, ParetoHealth, McKinsey Global Institute, and Scripps Health for bringing this content to our community.
Interested in learning more about CLS Insured? Explore membership and find out if your organization qualifies.
Frequently asked questions
CLS Insured is a self-insured health insurance plan developed through a partnership between California Life Sciences and HUB International’s Life Sciences Specialty Practice. It allows CLS member companies to better manage and spread the risk and expense of medical and prescription costs, with full transparency into where their healthcare dollars are going.
CLS Insured is available to life science companies and affiliated organizations with 100 to 1,500 eligible U.S. employees. Companies must be, or become, a CLS member to participate.
In a fully insured plan, your company pays a fixed premium to a carrier, which assumes the financial risk. In a self-insured model, your company directly funds employee healthcare claims, often with stop-loss protection to limit exposure on large claims. Self-insured plans typically offer more transparency, greater flexibility in plan design, and the potential for meaningful cost savings over time.
A captive is a risk-sharing structure in which a group of companies pool their healthcare risk together. This allows mid-sized employers to access the same cost management strategies and protections that large enterprises have used for years, while spreading the financial exposure across the group.
McKinsey’s research suggests that 68% of jobs in life sciences and pharma may require fundamental reimagination by 2030. Companies that wait for AI disruption to arrive before developing governance frameworks will find themselves reacting rather than leading. Getting your people, technology, and finance leaders aligned now, before implementation accelerates, is what separates proactive organizations from those playing catch-up.
A few concrete starting points: evaluate whether a self-funded or captive model is right for your organization, understand the contract timelines of providers in your current network, invest in employee health promotion and preventive care programs, and look closely at where your pharmacy spend is going. The more visibility you have into your plan data, the more strategic your decisions can be.